PHERECYDES PHARMA is a biopharmaceutical company developing new products against emerging bacteria, combining surveillance, detection and therapeutic tools based on phage technology.
Diversified libraries of bacteriophages are created by stochastic recombination of their targeting system, and biotechnological applications are derived, such as miniaturized biosensors and pharmaceutical applications.

Our mission is to develop new tools to rapidly detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.
The diversity of our phage libraries allied to the exceptional properties of bacteriophages allow us to address infectious problems in biodefense, environmental hygiene, food safety, veterinary and human therapeutics.

Downloads & News:

• NEW: Atlanta USA June 23-25, 2008: 12th Biodetection Technologies conference 2008 : Technological Responses to Biological Threats: Pherecydes  Pharma, first BMSystems' spin-off is invited to present its innovative response to biological threats:
  Session title: Engineered phage banks: A functional answer to bacteriological threats
  

• Company Presentation (French)
• Company Presentation (English)
• Paris-Medicen / Transversale Santé / Les biotechnologies face au bioterrorisme Octobre 2007
• To visit Bio-Modeling Systems (BMsystems) web site: www.bmsystems.net

Contact information
 

Thierry Raynaud, C.E.O.
thierry.raynaud@pherecydes-pharma.com

Pherecydes Pharma
48, rue de Lisbonne
75008 Paris, France